| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |